The association of PD-L1 expression status and the PD-1/PD-L1 inhibitor-related toxicity profile in non-small cell lung cancer

Related articles

1. Efficacy and safety of different PD-1 inhibitors as first-line treatment for advanced or metastatic squamous non-small cell lung cancer: A retrospective real-world study

   This article has 4 authors:

   1. Mengjiao Fu
   2. Jingjing Qu
   3. Jianya Zhou
   4. Jianying Zhou

2. Periphery TH/TS ratio and TP53 mutation predict the efficacy of ICI-based therapy in advanced non-small cell lung cancer with high PD-L1 expression

   This article has 4 authors:

   1. Fang Hao
   2. Qing Ma
   3. Linlin Zhang
   4. Diansheng Zhong

3. The Predictive efficacy of tumor mutational burden for immune Checkpoint Inhibitors in non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials

   This article has 7 authors:

   1. Min Ying
   2. Mengyu Hu
   3. Kegui Weng
   4. Yanyan Long
   5. Jing Chen
   6. Qianqian Lei
   7. Yongzhong Wu